The RUNX/CBFβ Complex in Breast Cancer: A Conundrum of Context
Cells · 2023
DOI: 10.3390/cells12040641 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cells, 2023. Verfasst von Adiba S Khan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Research UK Beatson Institute, Garscube Estate, Switchback Rd, Glasgow G61 1BD, UK. Hauptthemen laut MEDLINE: Core Binding Factor Alpha 2 Subunit, Core Binding Factor beta Subunit, Breast Neoplasms. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 191 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cancer Research UK.
Abstract (Originalsprache)
Dissecting and identifying the major actors and pathways in the genesis, progression and aggressive advancement of breast cancer is challenging, in part because neoplasms arising in this tissue represent distinct diseases and in part because the tumors themselves evolve. This review attempts to illustrate the complexity of this mutational landscape as it pertains to the RUNX genes and their transcription co-factor CBFβ. Large-scale genomic studies that characterize genetic alterations across a disease subtype are a useful starting point and as such have identified recurring alterations in CBFB and in the RUNX genes (particularly RUNX1). Intriguingly, the functional output of these mutations is often context dependent with regards to the estrogen receptor (ER) status of the breast cancer. Therefore, such studies need to be integrated with an in-depth understanding of both the normal and corrupted function in mammary cells to begin to tease out how loss or gain of function can alter the cell phenotype and contribute to disease progression. We review how alterations to RUNX/CBFβ function contextually ascribe to breast cancer subtypes and discuss how the in vitro analyses and mouse model systems have contributed to our current understanding of these proteins in the pathogenesis of this complex set of diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cancer Research UK Beatson Institute, Garscube Estate, Switchback Rd, Glasgow G61 1BD, UK.
- School of Cancer Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow G61 1QH, UK.
- School of Biodiversity One Health & Veterinary Medicine, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow G61 1QH, UK.
ORCID-Profile: Kirsteen J Campbell, Karen Blyth
Förderung
- Cancer Research UK
Zitieren
APA
Khan, A. S., Campbell, K. J., Cameron, E. R., & Blyth, K. (2023). The RUNX/CBFβ Complex in Breast Cancer: A Conundrum of Context. Cells. https://doi.org/10.3390/cells12040641
Vancouver
Khan AS, Campbell KJ, Cameron ER, Blyth K. The RUNX/CBFβ Complex in Breast Cancer: A Conundrum of Context. Cells. 2023. doi:10.3390/cells12040641
BibTeX
@article{Khan2023,
author = {Khan, Adiba S and Campbell, Kirsteen J and Cameron, Ewan R and Blyth, Karen},
title = {The RUNX/CBFβ Complex in Breast Cancer: A Conundrum of Context},
journal = {Cells},
year = {2023},
doi = {10.3390/cells12040641}
}
EUVIMED